← FDA Drug Approvals (Drugs@FDA)
RIFAMPIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2008-03-28
Drug application
- FDA Application #
ANDA065390- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIFAMPIN
- Generic name
- RIFAMPIN
- Active ingredients
- RIFAMPIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CHARTWELL MOLECULAR
- Manufacturer
- Chartwell RX, LLC
- First approval
- 2008-03-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown